Larvol Delta - BiomX-to-Present-Data-from-Ongoing-Phase-1b2a-Study-Evaluating-BX004-for-the-Treatment-of-Chronic-Pseudomonas-aeruginosa-Pulmonary-Infections-in-Patients-with-Cystic-Fibrosis-at-the-European-Respiratory-Society-ERS-International-Congress-2023

BX004 - BiomX

https://www.globenewswire.com/news-release/2023/09/07/2739444/0/en/BiomX-to-Present-Data-from-Ongoing-Phase-1b-2a-Study-Evaluating-BX004-for-the-Treatment-of-Chronic-Pseudomonas-aeruginosa-Pulmonary-Infections-in-Patients-with-Cystic-Fibrosis-at-t.html

Sep 7, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next